Activation-induced expression of human programmed death-1 gene in T-lymphocytes
about
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activationViral replication and paracrine effects result in distinct, functional responses of dendritic cells following infection with dengue 2 virusThe Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in MelanomaA regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humansThe role of the PD-1 pathway in autoimmunity and peripheral tolerancePD-1 regulates T cell proliferation in a tissue and subset-specific manner during normal mouse pregnancyLong-lasting immune responses 4 years after GAD-alum treatment in children with type 1 diabetes.PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta.Activation drives PD-1 expression during vaccine-specific proliferation and following lentiviral infection in macaques.CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction.A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates.The role of programmed cell death ligand-1 (PD-L1/CD274) in the development of graft versus host diseaseTargeting T cell costimulation in autoimmune disease.Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population.Multiple mechanisms of immune suppression by B lymphocytesInvolvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in miceProgrammed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancerBone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD).Eomesodermin(lo) CTLA4(hi) Alloreactive CD8+ Memory T Cells Are Associated With Prolonged Renal Transplant Survival Induced by Regulatory Dendritic Cell Infusion in CTLA4 Immunoglobulin-Treated Nonhuman Primates.Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockadeThe role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies.Programmed death 1 regulates development of central memory CD8 T cells after acute viral infection.Hepatoma cells up-regulate expression of programmed cell death-1 on T cells.Host bone marrow-derived IL-12 enhances donor T cell engraftment in a mouse model of bone marrow transplantation.The PD-1/PD-L1 (B7-H1) pathway in chronic infection-induced cytotoxic T lymphocyte exhaustion.Mammalian target of rapamycin integrates diverse inputs to guide the outcome of antigen recognition in T cells.Effects of immunoglobulin to prevent coronary allograft vasculopathy in heart transplantation.Immune checkpoint pathways: perspectives on myeloid malignancies.PD-1 and PD-L1 antibodies in cancer: current status and future directions.Genetic and Epigenetic Regulation of PD-1 ExpressionAn Evaluation of the Impact of PD-1 Pathway Blockade on Reproductive Safety of Therapeutic PD-1 Inhibitors.The Role of Immune Checkpoint Inhibition in the Treatment of Brain Tumors.Prokaryotic expression of the extracellular domain of porcine programmed death 1 (PD-1) and its ligand PD-L1 and identification of the binding with peripheral blood mononuclear cells in vitro.Structure and Dynamics of PD-L1 and an Ultra-High-Affinity PD-1 Receptor Mutant.Association between a PD-1 gene polymorphism and antisperm antibody-related infertility in Iranian men.High-affinity human PD-L1 variants attenuate the suppression of T cell activation.Posttranscriptional Control of PD-L1 Expression by 17β-Estradiol via PI3K/Akt Signaling Pathway in ERα-Positive Cancer Cell Lines.PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspective.PD-L1 expression in tumor metastasis is different between uveal melanoma and cutaneous melanoma.Donor-Derived Regulatory Dendritic Cell Infusion Maintains Donor-Reactive CD4+CTLA4hi T Cells in Non-Human Primate Renal Allograft Recipients Treated with CD28 Co-Stimulation Blockade.
P2860
Q24675931-87ABB21A-A37E-4CA3-AA12-0FE091FAC091Q27486878-35A64888-CDA5-4374-91D3-FE14F986B5F4Q28088496-1655A7FC-B383-4F8C-82D4-CF2E5834A51CQ28211167-178F794C-D1CA-4138-8933-93FD80230E5CQ28304161-74B24783-081B-4E97-B76C-4621DDD3D797Q33893319-3E1BF251-FD5A-47D1-A556-DB01375ECF8FQ34103574-5FE25E01-651B-4F49-AA4B-E347756A165DQ34347206-5D71AB8D-3511-4E12-BCBC-DBE4CCA65A42Q34377004-6133EFD3-00C5-4700-8FF7-C595FF45845BQ34390492-2A1F85B3-9D2F-45C0-BEAE-EE8004DA9874Q34403480-CC762F3B-A607-41C8-B395-258887468895Q34673038-DB93B321-E98E-4E50-B722-2240666C79F1Q34837371-70C86FB8-7EB3-4261-828C-7DAE824B16EBQ35630023-D9950162-D4FF-4093-971E-FCE17E5E544FQ35747533-9EB42FB1-C761-411C-8DBD-FFE28E8E4EB6Q35762001-C915454D-3356-4367-9715-D5BAF98A1FF4Q36069862-3E28D534-AF3D-44CA-97DA-67BE3B8FB695Q36251308-33C9D212-A0C4-4D5C-B4F3-66FBC8D4EE06Q36389157-EC3BDB27-D17A-40BA-B8FB-00036F027258Q36927966-54568504-DFF9-4806-9718-7C44AA38F12AQ37365776-887F8565-F2E1-416A-9460-B9A6B187574AQ37372772-EE9BB5A8-670B-454A-A527-7DD870D2BD30Q37413288-FF853AD3-5D12-4F62-93DB-D7A1482BE962Q37717313-821E9691-FDBE-4075-9BDA-021F6A5D83CCQ37940960-C041A9D5-DEE4-4FB2-9F3E-DC9FE0617394Q38007403-7A79660C-F1F0-4FD9-B9FF-119067DC5FBAQ38023873-81A01544-FD48-4690-9E6D-D47EA1EF59E2Q38750608-8335600C-A383-4399-B707-CD5013BC4E07Q38755931-5650E5DE-9F8F-4FDD-B76B-703A2CFB625AQ38761535-140E1E1D-6881-45DC-B21C-D337B9DFEFAAQ38803301-E0D3630B-A749-4BAA-8B6B-4FF845578C07Q38930244-17737A04-7E84-40AB-ACCD-9576B6D4E44EQ40242861-CC369B00-286F-46CA-A7FD-F9E3A202F326Q42387009-B81CD83B-6BC8-4D20-A0E1-953B749D33FDQ43106577-B26AF93B-FACD-4F83-960C-3DDDD4DF1051Q47123123-8A65C4EF-A885-4A99-94A9-8E898E76D86AQ49214132-FA5E79A5-0199-4239-9D78-E78F76BD4D28Q49357462-0F817B5D-F5A3-422F-B2B5-389D0B25ED37Q49557900-8D3381FD-E482-4EDC-A9F5-131D4C11A61FQ51742567-5821F5B9-0E9F-41AC-8B1D-C6465405CBDF
P2860
Activation-induced expression of human programmed death-1 gene in T-lymphocytes
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Activation-induced expression of human programmed death-1 gene in T-lymphocytes
@ast
Activation-induced expression of human programmed death-1 gene in T-lymphocytes
@en
Activation-induced expression of human programmed death-1 gene in T-lymphocytes
@nl
type
label
Activation-induced expression of human programmed death-1 gene in T-lymphocytes
@ast
Activation-induced expression of human programmed death-1 gene in T-lymphocytes
@en
Activation-induced expression of human programmed death-1 gene in T-lymphocytes
@nl
prefLabel
Activation-induced expression of human programmed death-1 gene in T-lymphocytes
@ast
Activation-induced expression of human programmed death-1 gene in T-lymphocytes
@en
Activation-induced expression of human programmed death-1 gene in T-lymphocytes
@nl
P2093
P356
P1476
Activation-induced expression of human programmed death-1 gene in T-lymphocytes
@en
P2093
P356
10.1006/EXCR.1997.3493
P407
P577
1997-04-10T00:00:00Z